Kinetics of Etheric Oils, Smart Textiles vs. Ointment

Common Cold Clinical Trial

Official title:

An Open Clinical Cross-Over Trial to Compare the Kinetics of Etheric Oils Applied Onto the Skin or Via Smart Textiles

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00299559
• Other study ID #: EK222122005
• Status: Completed
• Phase: Phase 1
• First received: March 3, 2006
• Last updated: February 12, 2009
• Start date: March 2006
• Est. completion date: August 2006

Study information

• Verified date: November 2007
• Source: Technische Universität Dresden
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Federal Institute for Drugs and Medical Devices
• Study type: Interventional

Clinical Trial Summary

The purpose of the study is to determine whether the application form of etheric oils (camphor, cineol and menthol) causes changes in the concentration of this agents in the exhaled air. The second aim of the study is to determine differences in the subjective convenience of the application forms. We will test an commercial ointment application vs. smart textiles. Smart textiles are new high-tech products with the unique possibility to combine the textiles with functional products e.g. pharmaceutical agents.

Description:

On the first appointment recruitment investigations will take place. After the person is enrolled to the study, the first determination of substances concentration in exhaled air and the convenience grade of the application form being exposed to will be achieved (study day 1). After a 7 days lasting washout phase on study day 2 newly determination of substances concentration and convenience grade of the other application will be assessed. Each study day will have an approximate duration of 11 h. During this time 9 samples of the persons exhaled air will be collected.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 6
• Est. completion date: August 2006
• Est. primary completion date: August 2006
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• caucasian

• Broca-index: between -20 and +25%

• who are willing and capable to confirm written consent to enrolment after ample information has been provided

• who are in a stable condition that it can be expected that no changes in relevant medical conditions will occur during the study.

Exclusion Criteria:

• subjects with any major relevant clinical abnormality (as based on extensive medical history, physical examination, vital signs)

• subjects with any major clinically relevant laboratory abnormality.

• subjects who participated in another trial with any investigational substance within the last 4 weeks

• subjects who smoke more than 15 cigarettes per day

• subjects who are known or suspected to be (social) drug dependent, incl. those drinking more than moderately and who are not willing to abstain from alcohol during the active study phase

• subjects who adhere to a diet or lifestyle (incl. competitive sports and weight lifting) that might interfere with the investigation

• subjects who are known or suspected not to comply with the study directives and/or who are known or suspected not to be reliable or trustworthy

• subjects who are known or suspected not to be capable of understanding and evaluating the information that is given to them as part of the formal information policy (informed consent), in particular regarding the risks and discomfort to which they would agree to be exposed

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Common Cold

Intervention

Drug:
• smart textiles containing menthol, camphor, cineol
application to skin

Locations

Country	Name	City	State
Germany	Department of clinical Pharmacology, Medical faculty Carl Gustav Carus, University of Technology Dresden	Dresden

Sponsors (1)

Lead Sponsor	Collaborator
Technische Universität Dresden

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Determination of agents concentration in exhaled air on study day 1+2. On each day 9 samples of exhaled air will be obtained.		24 h	No
Secondary	Grade of convenience of each application form will obtained at the end of each study day		48 h	No